Radiation-induced tumorigenesis in preneoplastic mouse mammary glands in vivo: Significance of p53 status and apoptosis

Molecular Carcinogenesis

Volumn 22, Issue 3, 1998, Pages 199-207

  Medina, Daniel ^a   Stephens, L Clifton ^b   Bonilla, Pedro J ^a   Hollmann, C Annette ^a   Schwahn, Denise ^a   Kuperwasser, Charlotte ^c   Jerry, D Joseph ^c   Butel, Janet S ^a   Meyn, Raymond E ^d  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c UNIVERSITY OF MASSACHUSETTS   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Apoptosis; Mammary glands; Mouse; P53; Radiation

Indexed keywords

PROTEIN P53;

ANIMAL TISSUE; APOPTOSIS; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; BREAST TUMOR; GENETIC STABILITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIATION CARCINOGENESIS;

ANIMALIA;

EID: 0031871432     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2744(199807)22:3<199::AID-MC8>3.0.CO;2-G     Document Type: Article

References (36)

1. Kelsey JL Gammon MD. The epidemiology of breast cancer. CA Cancer J Clin 41:146-165, 1991.
2. Allred DC Biological and genetic features of in situ breast cancer In: Silverstein MJ (ed), Ductal Carcinoma In Situ of the Breast. Williams and Wilkins, Baltimore, 1997, pp. 37-49.
3. Varmus HE, Godley LA, Roy S, et al. Defining the steps in a multistep mouse model for mammary carcinogenesis. Cold Spring Harb Symp Quant Biol 59:491-500, 1995.
4. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL. Human breast cancer: Correlation of relapse and survival with amplification of the HER2/neu oncogene. Science 235:177-187, 1987.
5. DairKee SH, Smith HS. Genetic analysis of breast cancer progression. Journal of Mammary Gland Biology and Neoplasia 1:139-151, 1996.
6. Gayther SA, Warren W, Mazoyer S, et al. Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype-phenotype correlation. Nat Genet 11:428-433, 1995.
7. Asch HL, Head K, Dong Y, et al. Widespread loss of gelsolin in breast cancers in humans, mice, and rats. Cancer Res 56:4841-4845, 1996.
8. Ozbun MA, Butel JS. Tumor suppressor p53 mutations and breast cancer: A critical analysis. Adv Cancer Res 66:71-141, 1995.
9. Lane D. p53 guardian of the genome. Nature 358:15-16, 1992.
10. Kuerbitz S, Plunkett B, Walsh W, Kastan M. Wild-type p53 is a cell cycle checkpoint determinant following radiation. Nature 89;7491-7495, 1992.
11. Yonish-Rouach E, Resnitzky D, Lotem J, Sachs L, Kimchi A, Oren M. Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature 352:345-347, 1991
12. Lowe S, Schmit E, Smith S, Osborne B, Jacks T. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362:847-849, 1993.
13. Medina D. Mammary tumors in mice. In: Foster HL, Small JD, Fox JG (eds), The Mouse in Biomedical Research, Vol 4. Academic Press, New York, 1982, pp. 373-396.
14. Medina D. Preneoplasia in mammary tumongenesis. In: Dickson RB, Lippman ME (eds), Mammary Tumor Cell Cycle, Differentiation and Metastases. Kluwer Academic Publishers, Norwell, MA, 1996, pp. 37-69.
15. Kittrell F, Osborn C, Medina D. Development of mammary preneoplasias in vivo from mouse mammary epithelial cell lines in vitro. Cancer Res 52:1924-1932, 1992.
16. Medina D, Kittrell F, Liu Y-J, Schwartz M. Morphological and functional properties of TM preneoplastic mammary outgrowths. Cancer Res 53:663-667, 1993.
17. Ozbun M, Jerry D, Kittrell F, Medina D, Butel J. p53 mutations selected in vivo when mouse mammary epithelial cells form hyperplastic outgrowths are not necessary for establishment of mammary cell lines in vitro. Cancer Res 53:1646-1652, 1993.
18. Jerry D, Ozbun M, Kittrell F, Lane D, Medina D, Butel J. Mutations in p53 are frequent in the preneoplastic stage of mouse mammary tumor development. Cancer Res 53:3374-3381, 1993.
19. Donehower L, Harvey M, Slagle B, et al. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumors. Nature 356:215-221, 1992.
20. Donehower L, Godley L, Aldaz C, et al. Deficiency of p53 accelerates mammary tumorigenesis in wnt-1 transgenic mice and promotes chromosomal instability. Genes Dev 9:882-895, 1995.
21. Meyn RE, Stephens LC, Mason KA, Medina D. Radiation-induced apoptosis in normal and pre-neoplastic mammary glands in vivo: Significance of gland differentiation and p53 status. Int J Cancer 65:466-472, 1996.
22. Medina D. Preneoplastic lesions in mouse mammary tumorigenesis. Methods in Cancer Research 7:3-53, 1973.
23. Clarke A, Purdie C, Harrison D, et al. Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 362:849-852, 1993.
24. Jerry DJ, Butel JS, Donehower LA, et al. Infrequent p53 mutations in 7,12-dimethylbenzanthracene-induced mammary tumors in BALB/c and p53 hemizygous mice. Mol Carcinog 9:175-183, 1994.
25. Stephens L, Schultheiss T, Small S, Ang K, Peters L. Response of parotid organ culture to radiation. Radiat Res 120:140-153, 1989.
26. Chomcznski P, Sacchi N. Single step method of RNA isolation by guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159, 1987.
27. MacCallum DE, Hupp TR, Midgely CA, et al. The p53 response to ionising radiation in adult and developing murine tissues. Oncogene 13:2575-2587, 1996.
28. Peto R. Guidelines in the analysis of tumor rates and death rates in experimental animals. Br J Cancer 29:101-105, 1974.
29. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemotherapy Reports 50:163-170, 1966.
30. MacGrogan G, Bonichon F, de Mascarel I, et al. Prognostic value of p53 in breast invasive ductal carcinoma: An immunohistochemical study on 942 cases. Breast Cancer Res Treat 36:71-81, 1995.
31. Muss HB, Thor AD, Berry DA, et al. c-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer. N Engl J Med 330:1260-1266, 1994.
32. Merritt A, Potten C, Kemp C, et al. The role of p53 in spontaneous and radiation-induced apoptosis in the gastrointestinal tract of normal and p53-deficient mice. Cancer Res 54:614-617, 1994.
33. Arends MJ, Wyllie AH. Apoptosis: Mechanisms and roles in pathology. Int Rev Exp Pathol 32:223-254, 1991.
34. Morgan WF, Day JP, Kaplan MI, McGhee EM, Limoli CL. Genomic instability induced by ionizing radiation. Radiat Res 146:247-258, 1996.
35. Ponnaiya B, Cornforth MN, Ullrich RL. Radiation-induced chromosomal instability in BALB/c and C57BL/6 mice: The difference is as clear as black and white. Radiat Res 147:121-125, 1997.
36. Kemp C, Wheldon T, Balmain A. p53-deficient mice are extremely susceptible to radiation-induced tumorigehesis. Nat Genet 8:66-69, 1994.